DHAVAL RAMESHCHANDRA SHAH (MD) – Hematology & Oncology Physician, NPI 1063743722
Hematology & Oncology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
48 HEMATOLOGY/ONCOLOGY in DE
Loading map...
Provider Addresses for DHAVAL RAMESHCHANDRA SHAH (MD)
ChristianaCare Helen F. Graham Cancer Center and Research Institute, 4701, Ogletown Stanton Road, Newark, New Castle County, Delaware, 19713, United States
SUITE 3400
NEWARK, DE 197132055
Phone: (609) 702-1900
Fax: (302) 366-1700
Mailing address matches the actual address.
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 14 Open Payments records for all available years, with a total value of $294.
Total Amount is formed as General ($294) + Research ($0) + Ownership ($0) = $294.
Last reported payment date: 2024-11-14 • Largest payer in this snapshot: Novartis Pharmaceuticals Corporation ($73).
Total Amount
$294
General + Research + Ownership
Payments
14
Total payment records
General Amount
$294
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-11-14
Latest reported date
Top Companies
Largest payers in this snapshot
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2016-03-31
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking this Medicare enrollment for revalidation, but has not published a due date.
Enrollment records
1
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20160331000144 | I | Hematology/Oncology | DE | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 27,200 | 35 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 19,880 | 12 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 9,360 | 15 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 8,700 | 12 | $0 |
| J9171 | Injection, docetaxel, 1 mg | 6,858 | 16 | $0 |
Insurance plans in this area (ZIP 19713)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| HEMATOLOGY/ONCOLOGY | DE | 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | 185 | 38 |
| HEMATOLOGY/ONCOLOGY | DE | 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 229 | 52 |
Group practice members
| Name | Specialty | State |
|---|---|---|
| H E M A T O L O G Y/ O N C O L O G Y | DE | |
| H E M A T O L O G Y/ O N C O L O G Y | DE | |
| H E M A T O L O G Y/ O N C O L O G Y | DE | |
| Physician Assistant | DE | |
| - | DE | |
| H E M A T O L O G Y/ O N C O L O G Y | DE | |
| Nurse Practitioner | DE | |
| Nurse Practitioner | DE | |
| H E M A T O L O G Y/ O N C O L O G Y | DE | |
| - | DE |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.